A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma
- PMID: 34077308
- PMCID: PMC8806743
- DOI: 10.1080/21655979.2021.1935400
A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma
Abstract
Papillary thyroid carcinoma (PTC) is a highly heterogeneous malignancy with diverse prognoses. Ferroptosis is a new type of cell death dependent on iron. Nevertheless, the predictive ability of ferroptosis-related genes for PTC is unclear. Based on the mRNA expression information from The Cancer Genome Atlas, we compared tumor and normal tissues in terms of the gene expression, for identifying differentially expressed genes (DEGs). Then, the risk score of a 5-gene signature was calculated and a prognostic model was established to test the predictive value of this gene signature by virtue of the LASSO Cox regression. The 5 genes were validated in PTC tissues by RT-qPCR.At last, functional analysis was implemented to investigate the underlying mechanisms. We found a total of 45 ferroptosis-related genes expressed differentially between tumor and normal tissues. 6 DEGs exhibited a significant relevance to the overall survival (OS) (P< 0.05). We classified patients into group with high risk and group with low risk based on the median risk score of a 5-gene signature. Patients in the group with low risk presented a remarkably higher OS relative to the group with high risk (P< 0.01). The Cox regression analysis displayed the independent predictive ability of the risk score. The receiver operating characteristic analysis helped to validate the predictive power owned by the gene signature. After validation, the 5 genes were abnormally expressed between PTC and normal tissues. Functional analysis showed two groups had different immune status. A new ferroptosis-related gene signature can predict the outcomes of PTC patients.
Keywords: Ferroptosis; gene model; overall survival; papillary thyroid carcinoma; prognosis.
Figures








Similar articles
-
Development and validation of a ferroptosis-related prognostic model for the prediction of progression-free survival and immune microenvironment in patients with papillary thyroid carcinoma.Int Immunopharmacol. 2021 Dec;101(Pt A):108156. doi: 10.1016/j.intimp.2021.108156. Epub 2021 Oct 6. Int Immunopharmacol. 2021. PMID: 34624650
-
Ferroptosis-related gene model to predict overall survival of papillary thyroid carcinoma.Am J Otolaryngol. 2021 Nov-Dec;42(6):103163. doi: 10.1016/j.amjoto.2021.103163. Epub 2021 Jul 26. Am J Otolaryngol. 2021. PMID: 34339960
-
Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.BMC Genomics. 2021 Jul 27;22(1):576. doi: 10.1186/s12864-021-07895-6. BMC Genomics. 2021. PMID: 34315405 Free PMC article.
-
Ferroptosis in thyroid cancer: Potential mechanisms, effective therapeutic targets and predictive biomarker.Biomed Pharmacother. 2024 Aug;177:116971. doi: 10.1016/j.biopha.2024.116971. Epub 2024 Jun 19. Biomed Pharmacother. 2024. PMID: 38901201 Review.
-
Anti-Ferroptosis: A Promising Therapeutic Method for Thyroid Cancer.Front Biosci (Landmark Ed). 2024 Feb 21;29(2):77. doi: 10.31083/j.fbl2902077. Front Biosci (Landmark Ed). 2024. PMID: 38420811 Review.
Cited by
-
Estimating disease-free survival of thyroid cancer based on novel cuprotosis-related gene model.Front Endocrinol (Lausanne). 2023 Sep 8;14:1209172. doi: 10.3389/fendo.2023.1209172. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37745716 Free PMC article.
-
Identification and Validation of a Prognostic Signature for Thyroid Cancer Based on Ferroptosis-Related Genes.Genes (Basel). 2022 Jun 1;13(6):997. doi: 10.3390/genes13060997. Genes (Basel). 2022. PMID: 35741758 Free PMC article.
-
Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients.Bioengineered. 2022 Feb;13(2):2498-2512. doi: 10.1080/21655979.2021.2017627. Bioengineered. 2022. PMID: 35067161 Free PMC article.
-
Identification of immune-related ferroptosis prognostic marker and in-depth bioinformatics exploration of multi-omics mechanisms in thyroid cancer.Front Mol Biosci. 2022 Aug 17;9:961450. doi: 10.3389/fmolb.2022.961450. eCollection 2022. Front Mol Biosci. 2022. PMID: 36060256 Free PMC article.
-
Ferroptosis in thyroid cancer: mechanisms, current status, and treatment.Front Oncol. 2025 Jan 23;15:1495617. doi: 10.3389/fonc.2025.1495617. eCollection 2025. Front Oncol. 2025. PMID: 39917169 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical